Clinical & Regulatory Cannabinoid Research Conference

In an industry first event the Centre for Medicinal Cannabis has drawn together a roster of political, scientific and public policy leaders to illuminate current research and regulatory opportunities and challenges in the use of cannabis-based medicinal products (CBMPs)

This one day, online event: UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation will have keynote addresses delivered by:

• Dr Paul Chrisp, Director, Centre for Guidelines, NICE
• George Freeman MP,  the newly appointed member of the Prime Minister's Task Force on Innovation, Growth and Regulatory Reform (TIGRR)
• Professor Roger Pertwee, Emeritus Professor, University of Aberdeen, Honorary Fellow of the British Pharmacological Society (BPS)

Alongside keynotes the conference themes will cover:

• Evidence and Real World Data
• Cannabinoids in Practice and
• Cannabinoids in Epilepsy

Featuring presentations from among others, Professor Helen Cross, Head of the Developmental Neuroscience Programme at UCL-Great Ormond Street Institute of Child Health, Sir John Tooke Executive Chairman of Academic Health Solutions and Dr Mikael Sodergren, Co-Founder and Managing Director of Sapphire Clinics.

It is timely to bring together the country's leading researchers, policy makers and industry working in cannabis-based medicine, to discuss the latest developments and identify the research evidence needed around the potential effectiveness of these types of treatment.

For more details, to view the full one day programme and to purchase tickets visit the summit website - www.cmcsummit.co.uk